These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34774137)

  • 41. Licit and illicit drug policies: a typology.
    Warner KE; Citrin T; Pickett G; Rabe BG; Wagenaar A; Stryker J
    Br J Addict; 1990 Feb; 85(2):255-62. PubMed ID: 2317593
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The international regime of drug control may violate the human right to life and security.
    Johnstad PG
    Int J Drug Policy; 2023 Mar; 113():103960. PubMed ID: 36758337
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How well do international drug conventions protect public health?
    Room R; Reuter P
    Lancet; 2012 Jan; 379(9810):84-91. PubMed ID: 22225673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Taming demons: the reduction of harm resulting from use of illicit drugs.
    Wodak A
    Aust N Z J Med; 1992 Apr; 22(2):204-8. PubMed ID: 1530547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. US Public Health Agency involvement in youth-focused illicit drug policy, planning, and prevention at the local level, 1999-2003.
    McBride DC; Terry-McElrath YM; VanderWaal CJ; Chriqui JF; Myllyluoma J
    Am J Public Health; 2008 Feb; 98(2):270-7. PubMed ID: 18172140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Older addicts.
    Fitzpatrick M
    Br J Gen Pract; 2011 Aug; 61(589):522. PubMed ID: 21801568
    [No Abstract]   [Full Text] [Related]  

  • 47. Can tobacco control endgame analysis learn anything from the US experience with illegal drugs?
    Reuter P
    Tob Control; 2013 May; 22 Suppl 1(Suppl 1):i49-51. PubMed ID: 23591511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of clandestine drug laboratories: need for evidence-based environmental health policies.
    Al-Obaidi TA; Fletcher SM
    Environ Health Prev Med; 2014 Jan; 19(1):1-11. PubMed ID: 24002745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug policy and the public good: evidence for effective interventions.
    Strang J; Babor T; Caulkins J; Fischer B; Foxcroft D; Humphreys K
    Lancet; 2012 Jan; 379(9810):71-83. PubMed ID: 22225672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The unmaking of 'evil': claiming space for rational discourse on US drug policy.
    Frydl KJ
    Addiction; 2019 Dec; 114(12):2119-2120. PubMed ID: 31646685
    [No Abstract]   [Full Text] [Related]  

  • 51. New Zealand's review of the Psychoactive Substances Act 2013: a missed learning opportunity ahead of the national cannabis law reform referendum?
    Rychert M; Wilkins C
    Addiction; 2019 Jun; 114(6):1129-1130. PubMed ID: 30801839
    [No Abstract]   [Full Text] [Related]  

  • 52. Traps in cannabis policies in Brazil.
    Laranjeira R; Martin D
    Braz J Psychiatry; 2019; 41(6):475-476. PubMed ID: 31826094
    [No Abstract]   [Full Text] [Related]  

  • 53. UNGASS 2016: Insights from Europe on the development of global cannabis policy and the need for reform of the global drug policy regime.
    Chatwin C
    Int J Drug Policy; 2017 Nov; 49():80-85. PubMed ID: 26795703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rethinking 'flexibilities' in the international drug control system-Potential, precedents and models for reforms.
    Collins J
    Int J Drug Policy; 2018 Oct; 60():107-114. PubMed ID: 28129946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The quandary of policy on illicit drugs.
    Penington D
    Aust N Z J Med; 2000 Feb; 30(1):75-80. PubMed ID: 10800884
    [No Abstract]   [Full Text] [Related]  

  • 56. Decriminalize drugs and use public health.
    Vogel L
    CMAJ; 2014 Jul; 186(10):E356. PubMed ID: 24890108
    [No Abstract]   [Full Text] [Related]  

  • 57. Illicit drugs.
    Morgan P
    J Public Health Policy; 1991; 12(1):20-3. PubMed ID: 2056102
    [No Abstract]   [Full Text] [Related]  

  • 58. Strategies to Reduce Illicit Trade of Regular Nicotine Tobacco Products After Introduction of a Low-Nicotine Tobacco Product Standard.
    Ribisl KM; Hatsukami DK; Huang J; Williams RS; Donny EC
    Am J Public Health; 2019 Jul; 109(7):1007-1014. PubMed ID: 31166743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug abuse and illicit drug trafficking.
    Manderson DR
    Med J Aust; 1998 Jun; 168(12):588-9. PubMed ID: 9673616
    [No Abstract]   [Full Text] [Related]  

  • 60. Psychiatry and the global drugs debate: what every psychiatrist needs to know.
    Bowden-Jones O; Sinclair J; Lingford-Hughes A
    Br J Psychiatry; 2020 Apr; 216(4):178-179. PubMed ID: 31685040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.